Syngenta reports 3% growth in integrated third-quarter sales at constant exchange rates, to $2.8 billion, with prices up 3% and volumes unchanged. Excluding solo glyphosate, sales of which are being deliberately reduced to improve profitability, sales were up 5%. Sales in the first nine months, $11.5 billion, were 3% higher at constant exchange rates. Syngenta does not disclose third-quarter earnings. Third-quarter integrated sales in Latin America were up 3%, or up 8% excluding glyphosate.
展开▼
